Dilemmas of EU Critique
Interdisciplinary Review of ValEUs · 24.07.2026
DOI: 10.5195/valeus.2026.19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary Review of ValEUs, online erschienen am 24.07.2026. Verfasst von Timm Beichelt. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This essay examines the character and function of scholarly EU critique, distinguishing it from political Eroskepticism and asking when such critique can be productive rather than destabilizing for the EU’s democratic project. Mapping critique across four arenas—international organization, economic and social policy, democracy and accountability, and identity—the essay draws on both critical theory and pragmatic sociology (Bourdieu, Boltanski) to argue that critique is substantively grounded only when linked to the lived experience of affected social actors. Tracing EU critique from the Community’s early technocratic disputes through the post-Maastricht democratic-deficit debates to today’s post-functionalist politicization, it contends that critique in three of the four arenas has grown more moderate, reflecting genuine institutional progress. The identity dimension, however, remains sharply contested: post-colonial critiques challenge the EU’s silence on its colonial past and its bearing on migration policy. The essay concludes that EU critique is best understood as a legitimate, largely reformist instrument of reflection, even as the identity arena exposes an unresolved tension between the EU’s universalist self-image and its incomplete reckoning with imperial history.
Zitieren
APA
Beichelt, T. (2026). Dilemmas of EU Critique. Interdisciplinary Review of ValEUs. https://doi.org/10.5195/valeus.2026.19
Vancouver
Beichelt T. Dilemmas of EU Critique. Interdisciplinary Review of ValEUs. 2026. doi:10.5195/valeus.2026.19
BibTeX
@article{Beichelt2026,
author = {Beichelt, Timm},
title = {Dilemmas of EU Critique},
journal = {Interdisciplinary Review of ValEUs},
year = {2026},
doi = {10.5195/valeus.2026.19}
}
EUVIMED